Download Pain Research in the News - American Academy of Pain Medicine

AAPM E-NEWS
Plan to attend next year's
Annual Meeting in Washington
DC,
March 24-27, 2011
Pre-meeting activities begin
Wednesday, March 23rd
Pain Medicine, D.C.
The Governing Voices of Pain:
Medicine, Science, and Government
September 27, 2010 - Your Latest News on the Specialty of Pain
Medicine
LATEST NEWS from the American Academy of Pain Medicine
Pain Research in the News
Pain Treatments/Trials in the News
Substance Abuse & Addiction Research
Practice Management & Coding Updates
Join the Discussion
AAPM Members in the News
AAPM Annual Meeting
• Scientific Abstract Submission Deadline is September 30, 2010
American Board of Pain Medicine (ABPM)
Pain Resources
Pain Abstracts in the News
PubMed Pain Abstracts
NIH Clinical Studies & Trials
Pain Research in the News
Most Report too Much Hospital Pain
September 22, 2010 [Source: UPI.com]
A study by German researchers surveyed over 3,000 hospital patients (2,250
surgical patients and nearly 1,000 non-surgical patients) and found that 56
percent of hospital patients indicated that their pain suffered in the hospital was
unbearable. Fifty-five percent of the hospital patients also reported that their
pain therapy in the hospital was unsatisfactory. The survey was part of the
Pain-Free Hospital Project. Full story...
View original article in Deutsches Aerzteblatt International...
High-Dose Aspirin Reduces Pain for Severe Headache and
Migraine
September 21, 2010 [Source: University of California, San Francisco]
Researchers at the University of California, San Francisco, found that high-dose
intravenous aspirin was effective for the treatment of severe headache and
migraine caused by drug withdrawal. Participants reported a significant
reduction in pain 25 percent of the time. Full story...
View related Cochrane Review...
Risk Factors for ER Visits in Chronic Opioid Users Identified
September 17, 2010 [Source: Modern Medicine]
Seeking a Pain Specialist?
A recent study in the Archives of Internal Medicine found that the use of
Schedule II opioids, headache, back pain, and substance use disorders were all
associated with emergency department visits and alcohol- or drug-related
encounters (ADEs). The risk was doubled for ADEs when the daily opioid use
was higher than 120 mg/d (morphine-equivalent). Full story...
View abstract on Archives of Internal Medicine...
Post your position in the AAPM
Career Center and reach more than
the 2,400 members of AAPM. The
network reaches beyond 30,000
professionals in healthcare.
AAPM Releases
Pain Position
Paper
Plenary Proceedings of
the 24th Annual Meeting
Plenary Proceedings of the 24th
Annual Meeting contains exciting,
forward thinking perspectives currently
driving the emerging field of Pain
Medicine.
Order your copy TODAY
Price: $79
UC Davis Scientists Find Link Between Arthritis Pain Reliever and
Cardiovascular Events
September 13, 2010 [Source: UC Davis Health System]
Researchers from the University of California, Davis and Peking University in
China, used metabolomic profiling to analyze murine (rodent) plasma to
discover that Vioxx caused a dramatic increase in regulatory lipid that could be
a major contributor to heart attacks and strokes associated with high-levels of
the drug and other selective COX-2 inhibitors. Scientists hope this discovery
will lead to the development of safer drugs for those suffering with acute or
chronic pain. Full story...
View a review at NIH Public Access (Mol. Cell Pharmacol.)...
Scripps Research Scientists Identify Molecules Involved in Touch
and Other Mechanically Activated Systems
September 2, 2010 [Source: The Scripps Research Institute]
Researchers at Scripps Research Institute identified two proteins, Piezo1 and
Piezo2, which are involved in cellular response to mechanical stimulation.
Scientists believe that these proteins may be important targets for research in
pain, deafness, and cardiac and kidney dysfunction. Full story...
View original abstract at Science...
Back to top
Pain Treatments/Trials in the News
Fuisz Announces Further Advances in Drug Compliance
Verification for Opioids
September 21, 2010 [Source: PR Newswire]
Fuisz Pharma introduces its Closed Loop Diagnostic System that will help
physicians identify compliant and non-compliant patients' use of opioids. Full
story...
Potential First-in-Class Compound, Reveals New Approach to the
Treatment of Pain (D3)
September 20, 2010 [Source: Business Wire]
4 easy ways to order:
Phone: 847-375-4731
Fax: 847-375-6477
Email: [email protected]
Mail: AAPM
P.O. Box 839
Glenview, IL 60025-0839
ORDER FORM
Researchers at the Italian Institute of Technology and the University of
California, Irvine, presented results from a preclinical study that show the
potential drug URB937, a potent, second-generation inhibitor of the enzyme
fatty acid amide hydrolase, controlled pain and inflammation locally at the site.
The drug boosted levels of anandamide in peripheral tissues. Full story...
View at original article at Nature Neuroscience...
EuroPharma Release: BCM-95 Demonstrates Superior AntiInflammatory Effects, Baylor University Medical Center Study
September 16,2010 [Source: ClinicaSpace]
Researchers at Baylor University Medical Center found that BCM-95, a new
patented extract of curcumin, was absorbed up to 10 times better than
conventional curcumin, possessing potent anti-inflammatory properties. Full
story...
View related article at NIH Public Access (Curr Aging Sci.)...
Arcion Therapeutics Receives FDA Fast Track Designation for
ARC-4558 for the Treatment of Pain Associated with Painful
Diabetic Neuropathy
September 14, 2010 [Source: BioSpace]
PATIENT INFORMATION
Arcion Therapeutics’s ARC-4558, a 0.1% gel formulation of clonidine
hydrochloride for topical administration for treatment of painful diabetic
neuropathy, has been placed in the Fast Track program of the FDA and is now
set to enter Phase 3 studies. Full story...
Diamyd Medial Issues Positive Phase I Data for Chronic Pain
Patient Education Videos
Now Available Online
Online videos are now available in the
Patient Portal section of the AAPM
website for your patients to view:
View "Finding Relief: Pain
Management for Older Adults" video
View "Managing Chronic Pain, A
Guide for Patients" video
Educational Booklet and
DVD
Copies of the new educational booklet
and DVD, Finding Relief: Pain
Management for Older Adults are
available to members free of charge,
with the addition of a modest shipping
fee. To request copies of this resource
email: [email protected].
UPDATES
The AAPM Power Point
Presentation on the
Federal Regulations for
Prescribing has been
updated as of 6/01/2010.
View this new presentation.
Revised AAPM Ethics
Charter
Includes statement on conflicts of
interest.
Therapy
September 13, 2010 [Source: Trading Markets]
Diamyd Medical will begin Phase II clinical trial of its NP2 as a potential therapy
for chronic pain. This is the first drug candidate using Diamyd’s proprietary
Nerve Targeting Drug Delivery System platform, which focuses on delivery of
therapeutic compounds directly to the nervous system. Full story...
Back to top
Substance Abuse & Addiction Research
National Survey Reveals Increases in Substance Use from 2008
to 2009
September 16, 2010 [Source: SAMHSA]
A National Survey on Drug Use and Health (NSDUH) by SAMHSA found that
the overall rate of current illicit drug use in the U.S. increased from 8.0 percent
of the population aged 12 and older in 2008 to 8.7 percent in 2009 and was
largely due to increased marijuana use. The study also found that the nonmedical use of prescription drugs rose from 2.5 percent in 2008 to 2.8 percent
in 2009 among the population. Full story...
View complete survey at SAMHSA...
Substance Abuse Admissions Double Among Older Adults
September 9, 2010 [Source: Medline Plus]
The National Survey on Drug Use and Health also reported that the number of
people aged 50 and older admitted for substance abuse treatment rose from
102,700 in 1992 to 231,200 in 2008, with 65.8 percent of the admissions
among Caucasians. Full story...
Back to top
Practice Management & Coding Updates
CODING & REIMBURSEMENT UPDATES
New ICD-9-CM Codes Effective October 1, 2010
Emily Hill, PA
Need Facts on Pain?
Updated: Visit AAPM's "Facts on
Pain" section in the Patient Center of
the AAPM website, which now
includes detailed references to each
fact. These are helpful to have on
hand for media calls. Read more...
Affiliate Membership
Are the members of your pain team
AAPM members?
ICD-9-CM changes have been released and become effective October 1, 2010.
A complete list of all ICD-9-CM changes can be found in the front of most
editions of the manual. The number of annual changes is expected to be
minimal over the next several years as we move to ICD-10 on October 1, 2013.
Read more...
PRACTICE MANAGEMENT
The Practice Management section of the AAPM website offers practical tools
and resources for you to use in your pain practice, as well as coding updates,
reimbursement news, and other information that impacts your practice.
Visit this helpful section on the website
Back to top
Join the Discussion
Latest Topic in the AAPM Members' Discussion Forum
An AAPM member from Teaneck, New Jersey, asked the question, "Does
anyone have experience prescribing Marinol for pain? Despite its schedule 3
Affiliate membership information...
The American Board of
Pain Medicine (ABPM) is
committed to the certification of
qualified physicians in the field of Pain
Medicine. Visit abpm.org to view
ABPM's mission, vision, and
objectives.
Pain Medicine:
September, 2010
Highlights:
EDITORIAL
Gender Differences in the Affective
Processing of Pain: Brain
Neuroscience and Training in
"Biopsychosocial" Pain Medicine
SPINE SECTION
Efficacy of Fluoroscopically Guided,
Contrast-Enhanced Lumbosacral
Interlaminar Epidural Steroid
Injections: A Pilot Study
PALLIATIVE CARE SECTION
Factors Associated with Clinician
Intention to Address Diverse Aspects
of Pain in Seriously Ill Outpatients
PSYCHOLOGY, PSYCHIATRY &
BRAIN NEUROSCIENCE
Differences in Pain, Psychological
Symptoms, and Gender Distribution
among Patients with Left- vs RightSided Chronic Spinal Pain
ACUTE PAIN SECTION
Continuous Transversus Abdominis
Plane (TAP) Block Catheters in a
Combat Surgical Environment
View all topics slated for the next
issue of Pain Medicine Journal or go
to the Library section of the AAPM
website for more information.
MEMBERSHIP
AAPM Membership Renewals
Membership renewals are currently
being sent out. Don't miss the
opportunity to continue being a part of
the primary organization for physicians
practicing in the specialty of pain
medicine. As a member you will
continue to receive the AAPM ENews, Pain Medicine, the official
journal of AAPM, as well as
representation and advocacy in
Washington DC, up-to-date coding
information, discounts on AAPM's
Annual Meeting, and a host of other
status there are obvious stigmas attached. Is there increased risk of DEA
scrutiny with occasional prescriptions? With frequent prescriptions?"
Visit the Discussion Forum to post your comments (login required)
Back to top
AAPM Members in the News
Small Study Suggests Electrical Stimulation of the Brain Can
Ease Migraine Pain
September 18, 2010 [Source: Los Angeles Times]
AAPM member, Joel Saper MD, is featured in a Los Angeles Times article
discussing a small pilot study on the use of electrical stimulation on the occipital
nerve to treat chronic migraine. Full story...
Washington Legislation Targets Opioid Abuse, But at What Cost?
September 2010 [Source: Pain Medicine News]
AAPM President, Eduardo Fraifeld MD, and
AAPM Co-Chair of the Research Committee, Alex
Cahana MD, discuss the impact of the new
Washington State legislation, which introduces
“measurement-based care” in the field of pain
management. Full story...(login required)
A Different Kind of Pain
September 9, 2010 [Source: msnbc.com]
Dr. Alex Cahana discusses phantom pain in an interview featured online on
Nightly News with Brian Williams. View video...
Back to top
AAPM Annual Meeting
AAPMedicine's 2011 Call for Scientific Poster Abstracts:
DEADLINE: September 30, 2010
The 2011 Program Committee invites you to submit proposals for scientific
abstracts to be presented at the AAPM 27th Annual Meeting, March 24-27,
2011, at the Gaylord National Hotel and Convention Center in National Harbor,
MD.
2011 - Poster Award
The 2011 Scientific Poster Abstract Committee will select up to 5 scientific
poster abstract submitters to present their research during a "live" Plenary
Research Highlights session held Saturday morning during the 2011 Annual
Meeting. This honor includes the recognition of "Faculty" status at the meeting.
As faculty of the annual meeting, the presenters' airfare, lodging and Annual
Meeting registration are complementary (up to a dollar amount that will be
specified at a later date.) If there are questions regarding this amount, please
email [email protected].
As an additional reward, each of these presenters will also receive
complementary meeting registration for the 2012 AAPM Annual Meeting in
Palm Springs, California.
member benefits.
Pay dues online or for phone
assistance, please call customer
service at 847/375-4731.
Bring in a new, paid, active AAPM
member and receive the Plenary
Proceedings of the 24th Annual
Meeting, which contains exciting,
forward thinking perspectives currently
driving the emerging field of Pain
Medicine. A $79 value. Contact
[email protected] to
receive your thank you for referring a
new AAPM.
With membership at an
unprecedented level, more than 2,400
physicians and their pain teams are
part of this premier medical specialty
society, practicing in pain medicine
from origins in anesthesiology,
neurosurgery, neurology, physiatry,
and psychiatry. For more than 25
years, the American Academy of Pain
Medicine (AAPM) has provided
education, training, advocacy and
research in the specialty of pain
medicine. Consider joining AAPM
today and become part of this growing
medical specialty society. Visit
www.painmed.org for more
information.
AAPM on Social
Networking Sites
Join the AAPM Linked-In Group
and become a "fan" of AAPM on
Facebook
Hurry! AAPM’s Scientific Abstract Submission Deadline is
September 30th!
Click Here for complete details.
For more information, or to apply online, visit: www.painmed.org or call Mary
O’Keefe 847-375-4809.
Back to top
American Board of Pain Medicine (ABPM)
ABPM Now Accepting 2011 Examination Applications
Deadline: October 1, 2010
There is still time to apply for the American Board of Pain Medicine (ABPM)
2011 certification and recertification examinations. The final filing postmark
deadline for both examinations is Friday, October 1, 2010. Both examinations
are available in an electronic format, eliminating the need to travel to one
location to take a paper and pencil exam. Online testing is offered through ACT
testing sites nationwide during the 3-week window of Saturday, April 2, 2011
through Saturday, April 23, 2011. For information on ACT test center locations,
visit http://www.act.org/actcenters/locate/index.html.
If you are interested in certifying with ABPM, or if you are a Diplomate who
needs to recertify, please visit www.abpm.org to download the applicable
examination materials, or contact the ABPM office to request a copy of the
Examination packet at (847) 375-4726 or [email protected].
Back to top
Pain Resources
American Pain Foundation Launches PainSAFE™
The American Pain Foundation (APF) launched PainSAFE™ (Pain Safety &
Access For Everyone), a new educational initiative designed for people with
pain and health care professionals. AAPM treasurer, Lynn Webster MD,
initiated the project for the National Pain Foundation (NPF), which was then
moved forward and completed after NPF's assets were integrated into the
American Pain Foundation this past May. Visit PainSafe™
Back to top
Pain Abstracts in the News
Botulinum Toxin for Shoulder Pain
September 8, 2010 [Source: Cochrane Reviews]
Abstract: Background: Recent evidence suggests an anti-nociceptive effect of
botulinum toxin. Objectives: To compare the efficacy and safety of botulinum
toxin in comparison to placebo or other treatment options for shoulder pain.
Read more...
View Intervention Review at The Cochrane Library...
Golimumab Eases Sleep in Ankylosing Spondylitis
September 2010 [Source: Arthritis Care & Research]
Abstract: Objective: To evaluate the effect of golimumab on sleep disturbance
in patients with active ankylosing spondylitis (AS).
Read more...
View drug review at the journal of Core Evidence...
Identification, Treatment, and Clinical Outcomes of Neuropathic
Pain for the Primary Care Physician
August 2010 [Source: Journal of Clinical Outcomes Management]
Abstract: Objective: To provide an overview of and roadmap to using the
options available for the appropriate diagnosis and treatment of neuropathic
pain.
Read more...
Back to top
PubMed Pain Abstracts
The following abstracts are posted at PubMed.gov
Post-Traumatic Stress Disorder, Drug Abuse and Migraine: New
Findings from the National Comorbidity Survey Replication (NCSR)
Cephalalgia. 2010 Sep 2. [Epub ahead of print]
Peterlin BL, Rosso AL, Sheftell FD, Libon DJ, Mossey JM, Merikangas KR.,
Johns Hopkins University, USA.
Abstract: Background: Post-traumatic stress disorder (PTSD) has been shown
to be associated with migraine and drug abuse. Methods: This was an analysis
of data from the National Comorbidity Survey Replication (NCS-R) to evaluate
the association of PTSD in those with episodic migraine (EM) and chronic daily
headache (CDH).
PMID: 20813779 [PubMed - as supplied by publisher]
Read more...
View related article at Pediatrics...
Milnacipran for Treatment of Fibromyalgia
Ann Pharmacother. 2010 Sep;44(9):1422-9. Epub 2010 Aug 17.
Kyle JA, Dugan BD, Testerman KK.
Samford University, Birmingham, AL, USA.
Abstract: OBJECTIVE: To review the pharmacology, pharmacokinetics, efficacy,
and safety of milnacipran and evaluate relevant clinical trial data.
PMID: 20716692 [PubMed - in process]
Read more...
View abstract at The Annals of Pharmacotherapy...
View related article at Arthritis & Rheumatism...
Clinical Characteristics of Veterans Prescribed High Doses of
Opioid Medications for Chronic Non-Cancer Pain
Pain. 2010 Aug 27. [Epub ahead of print]
Morasco BJ, Duckart JP, Carr TP, Deyo RA, Dobscha SK.
Mental Health and Clinical Neurosciences Division, Portland VA Medical Center,
Department of Psychiatry, Oregon Health & Science University, USA.
Abstract: Little is known about patients prescribed high doses of opioids to treat
chronic non-cancer pain, though these patients may be at higher risk for
medication-related complications. We describe the prevalence of high-dose
opioid use and associated demographic and clinical characteristics among
veterans treated in a VA regional healthcare network.
PMID: 20801580 [PubMed - as supplied by publisher]
Read more...
A Multicenter, Placebo-Controlled, Double-Blind, MultipleCrossover Study of Fentanyl Pectin Nasal Spray (FPNS) in the
Treatment of Breakthrough Cancer Pain
Pain. 2010 Aug 25. [Epub ahead of print]
Portenoy RK, Burton AW, Gabrail N, Taylor D; on behalf of the Fentanyl Pectin
Nasal Spray 043 Study Group.
Beth Israel Medical Center, New York, NY, USA.
Abstract: This randomized, double-blind, crossover study assessed the efficacy
and tolerability of a new rapid onset nasal fentanyl formulation (Fentanyl Pectin
Nasal Spray; FPNS) for breakthrough cancer pain (BTCP). Eighty-three of 114
patients experiencing one to four BTCP episodes/day while taking 60mg/day
of oral morphine or equivalent successfully identified an effective dose of FPNS
during a titration phase and entered a double-blind phase in which 10 BTCP
episodes were treated with this effective dose (7) or placebo (3). Compared
with placebo, FPNS significantly improved mean summed pain intensity
difference (SPID) from 10min (P<0.05) until 60min (P<0.0001), including the
primary endpoint at 30min (P<0.0001).
PMID: 20800358 [PubMed - as supplied by publisher]
Read more...
Pharmacologic Management of Chronic Pain
Korean J Pain. 2010 Jun;23(2):99-108. Epub 2010 May 31.
Park HJ, Moon DE.
Department of Anesthesiology and Pain Medicine, School of Medicine, The
Catholic University of Korea, Seoul, Korea.
Abstract: Chronic pain is a multifactorial condition with both physical and
psychological symptoms, and it affects around 20% of the population in the
developed world. In spite of outstanding advances in pain management over the
past decades, chronic pain remains a significant problem. This article provides
a mechanism- and evidence-based approach to improve the outcome for
pharmacologic management of chronic pain.
PMID: 20556211 [PubMed - in process]
Read more...
PMCID: PMC2886242
Free article available on PubMed Central...
Back to top
NIH Clinical Studies & Trials
The following studies and trials are posted at ClinicalTrials.gov
Methadone in Neuropathic Pain
This study is not yet open for participant recruitment.
First Received: September 17, 2010
Sponsor: Capital District Health Authority, Canada
Collaborators: Canadian Institutes of Health Research (CIHR), Nova Scotia
Health Research Foundation, Dalhousie University
Information provided by: Capital District Health Authority, Canada
ClinicalTrials.gov Identifier: NCT01205516
Stated Purpose: There is an important need for inexpensive drugs that treat
neuropathic pain. Early research suggests that methadone may be a good,
inexpensive drug to treat neuropathic pain. Methadone is available in a low cost
powder that is easily prepared for different routes of administration. This study
will look at the effect and safety of methadone compared to the regular
treatment of morphine for the treatment of chronic neuropathic pain.
Read more...
IRB-HSR# 13957: IV Lidocaine for Patients Undergoing Primary
Breast Cancer Surgery: Effects on Postoperative Recovery and
Cancer Recurrence
This study is enrolling participants by invitation only.
First Received: September 15, 2010 Last Updated: September 16, 2010
Sponsor: University of Virginia
Principal Investigator: Mohammed Tiouririne, MD, UVA Dept of Anesthesiology
Information provided by: University of Virginia
ClinicalTrials.gov Identifier: NCT01204242
Stated Purpose: The purpose of this study is to determine whether a local
anesthetic drug (lidocaine) given during anesthesia intravenously (IV) through a
needle in your vein,), can, 1.) Help decrease pain after surgery, 2.) Have you
need less pain medication, 3.) Have less side effects like nausea and vomiting
following your surgery. 4.) Help to prevent chronic pain, and 5.) Affect
recurrence of cancer after surgery.
Read more...
Read related article at Revista Brasileira de Anestesiologia (Scroll down for
English Version)...
A Study to Investigate the Analgesic Efficacy of AZD2423
Compared With Placebo After 28 Days Treatment in Patients With
Painful Diabetic Polyneuropathy
This study is not yet open for participant recruitment.
First Received: September 13, 2010
Sponsor: AstraZeneca
Study Director: Bror Jonzon, AstraZeneca R&D Södertälje
Information provided by: AstraZeneca
ClinicalTrials.gov Identifier: NCT01201317
Stated Purpose: A study to investigate the analgesic efficacy of AZD2423
compared with placebo after 28 days treatment in patients with painful diabetic
polyneuropathy.
Read more...
A Rheumatoid Arthritis Study in Patients on a Background
Treatment of Methotrexate
This study is not yet open for participant recruitment.
First Received: September 8, 2010
Sponsor: Eli Lilly and Company
Information provided by: Eli Lilly and Company
ClinicalTrials.gov Identifier: NCT01198002
Stated Purpose: The primary purpose of this study is to help answer if
LY2127399 is safe and effective in the treatment of rheumatoid arthritis while
on a background treatment of methotrexate.
Read more...
OXN PR vs Placebo in Opioid-naive Subjects Suffering From
Severe Pain Due to Bladder Pain Syndrome (BPS)
This study is not yet open for participant recruitment.
First Received: September 7, 2010 Last Updated: September 8, 2010
Sponsor: Mundipharma Research GmbH & Co KG
Information provided by: Mundipharma Research GmbH & Co KG
ClinicalTrials.gov Identifier: NCT01197261
Stated Purpose: The study compares the analgesic efficacy of OXN PR vs
placebo in opioid-naive subjects suffering from severe pain due to Bladder Pain
Syndrome.
Read more...
View related article at NIH Public Access at J Urol...
View related article at NIH Public Access at Neurourol Urodyn...
View related article at Reviews in Obstetrics & Gynecology...
Back to top
Click here to unsubscribe.
American Academy of Pain Medicine
8735 W. Higgins Road, Suite 300, Chicago, IL 60631
847/375-4731 847/375-6477 Fax
[email protected] www.painmed.org